Key result
Review provides evidence-based guidance on selecting heart rhythm monitors for symptomatic and high-risk patients.
Why the study?
Recent technological advances have diversified cardiac arrhythmia diagnostic options, necessitating guidance to help clinicians select the most appropriate and cost-effective test for symptomatic or high-risk patients.
This review provides evidence-based guidance on selecting appropriate heart rhythm monitoring tools for diagnosing arrhythmias in symptomatic and high-risk patients.
Answers are grounded in this paper and cite their sources.
Guides arrhythmia monitoring selection in symptomatic and high-risk patients; leaves open optimal strategies pending prospective validation.
Recent technological advances have facilitated and diversified the options available for the diagnosis of cardiac arrhythmias. Ranging from simple resting or exercise electrocardiograms to more sophisticated and expensive smartphones and implantable cardiac monitors. These tests and devices may be used for varying periods of time depending on symptom frequency. The choice of the most appropriate heart rhythm test should be guided by clinical evaluation and optimized following accurate characterization of underlying symptoms, 'red flags', risk factors, and consideration of cost-effectiveness of the different tests. This review provides evidence-based guidance for assessing suspected arrhythmia in patients who present with symptoms or in the context of screening, such as atrial fibrillation or advanced conduction disturbances following transcatheter aortic valve implantation in high-risk groups. This is intended to help clinicians choose the most appropriate diagnostic tool to facilitate the management of patients with suspected arrhythmias.
No takes yet. Share an insight, caveat, or question.
Carrington et al. (2022) conducted a review in Cardiac arrhythmias. Heart rhythm monitoring tools was evaluated. This review provides evidence-based guidance on selecting appropriate heart rhythm monitoring tools for diagnosing suspected arrhythmias in symptomatic patients and high-risk screening groups.
Synapse has enriched 10 related papers. Consider them for comparative context: